Toray Invests In Mitsui Pharmaceutical Subsidiary With China In Mind
This article was originally published in PharmAsia News
Executive Summary
Toray has obtained a 20% share in Tokyo-based Japan MicroBiopharma, a biopharmaceutical subsidiary of Mitsui & Co.